MTHFR homozygous mutation and additional risk factors for cerebral infarction in a large Italian family.

[1]  R. B. Caldwell,et al.  Homocysteine induces endothelial dysfunction via inhibition of arginine transport. , 2007, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[2]  V. Ganesan,et al.  Thrombophilia and first arterial ischaemic stroke: a systematic review , 2005, Archives of Disease in Childhood.

[3]  S. Karasalihoǧlu,et al.  Factor V Leiden Mutation and Other Thrombophilia Markers in Childhood Ischemic Stroke , 2005, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  J. R. Chaudhuri,et al.  MTHFR C677T gene mutation as a risk factor for arterial stroke: a hospital based study , 2005, European journal of neurology.

[5]  G. Montalescot,et al.  Does the polymorphism 677C-T of the 5,10-methylenetetrahydrofolate reductase gene contribute to homocysteine-related vascular disease? , 1998, Journal of Inherited Metabolic Disease.

[6]  D. Green.  Thrombophilia and Stroke , 2003, Topics in stroke rehabilitation.

[7]  C. Martínez-Murillo,et al.  Evaluación nacional del diagnóstico de la resistencia a la proteína C activada , 2003 .

[8]  P. Maciel,et al.  Inherited and acquired risk factors and their combined effects in pediatric stroke. , 2003, Pediatric neurology.

[9]  K. Voudris,et al.  Congenital Microcephaly in Two Infants With the Factor V Leiden Mutation , 2002, Journal of child neurology.

[10]  K. Furie,et al.  Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: Results of a meta-analysis , 2002, Neurology.

[11]  D. Hirtz,et al.  Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. , 2002, Pediatrics.

[12]  K. Nelson,et al.  Cerebrovascular Disorders in Children With the Factor V Leiden Mutation , 2001, Journal of child neurology.

[13]  M Yamamoto,et al.  Effects of homocysteine on the binding of extracellular‐superoxide dismutase to the endothelial cell surface , 2000, FEBS letters.

[14]  G. Rechavi,et al.  Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. , 2000, Stroke.

[15]  E. Monrós,et al.  Children With Stroke: Polymorphism of the MTHFR Gene, Mild Hyperhomocysteinemia, and Vitamin Status , 2000, Journal of child neurology.

[16]  A. von Eckardstein,et al.  Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. , 1999, Blood.

[17]  G. deVeber,et al.  Prothrombotic disorders in infants and children with cerebral thromboembolism. , 1998, Archives of neurology.

[18]  H. Markus,et al.  A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. , 1997, Stroke.

[19]  F. Costa,et al.  The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[20]  U. Nowak‐Göttl,et al.  Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.